1. What is the scale of the future diabetes epidemic, and how certain are we about it?

   • S. H. Wild
   • N. G. Forouhi

   Commentary 21 March 2007 Pages: 903 - 905

2. Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant?

   • K. E. White
   • S. M. Marshall
   • R. W. Bilous

   For Debate 27 February 2007 Pages: 906 - 912

   

3. Metabolic effects of interventions to increase exercise in adults with type 2 diabetes

   • V. S. Conn
   • A. R. Hafdahl
   • P. J. Nielsen

   Meta-Analysis 07 March 2007 Pages: 913 - 921

4. Improved survival rate in patients with diabetes and end-stage renal disease in Denmark

   • V. R. Sørensen
   • E. R. Mathiesen
   • B. Feldt-Rasmussen

   Article 28 February 2007 Pages: 922 - 929

   

5. Association of glucose levels and glucose variability with mood in type 1 diabetic patients

   • N. Hermanns
   • C. Scheff
   • T. Haak

   Short Communication 17 March 2007 Pages: 930 - 933

6. Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way

   • A. G. Mainous III
   • R. Baker
   • A. Majeed

   Article Open access 21 November 2006 Pages: 934 - 940

7. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study

   • G. Bruno
   • F. Merletti
   • P. Cavallo-Perin

   Article 02 March 2007 Pages: 941 - 948

8. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study

   • N. G. Forouhi
   • A. H. Harding
   • N. J. Wareham

   Article 02 March 2007 Pages: 949 - 956

   

9. School performance in children with type 1 diabetes—a population-based register study

   • G. Dahlquist
   • B. Källén
   • On behalf of the Swedish Childhood Diabetes Study Group

   Article 27 February 2007 Pages: 957 - 964

   

10. The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes

    • M. K. Bulsara
    • C. D. J. Holman
    • T. W. Jones

    Article 27 February 2007 Pages: 965 - 971

    

11. A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus

    • N. Shaat
    • Å. Lernmark
    • L. Groop

    Article 07 March 2007 Pages: 972 - 979

12. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population

    • T. Hayashi
    • Y. Iwamoto
    • S. Maeda

    Article 06 March 2007 Pages: 980 - 984

13. Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians

    • M. Traurig
    • R. L. Hanson
    • L. J. Baier

    Short Communication 27 February 2007 Pages: 985 - 989

14. Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach

    • K. Kaňková
    • A. Stejskalová
    • J. Ott

    Article 08 March 2007 Pages: 990 - 999

    

15. Low levels of glucose transporters and \( K^{ + }_{{ATP}} \) channels in human pancreatic beta cells early in development

    • C. C. Richardson
    • K. Hussain
    • M. R. Christie

    Article 23 March 2007 Pages: 1000 - 1005

    

16. Global profiling of genes modified by endoplasmic reticulum stress in pancreatic beta cells reveals the early degradation of insulin mRNAs

    • P. Pirot
    • N. Naamane
    • D. L. Eizirik

    Article 01 March 2007 Pages: 1006 - 1014

    

17. Prospective prediction of spontaneous but not recurrent autoimmune diabetes in the non-obese diabetic mouse

    • J. D. Trudeau
    • T. Chandler
    • R. Tan

    Article 02 March 2007 Pages: 1015 - 1023

    

18. Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men

    • H. B. Holt
    • S. H. Wild
    • C. D. Byrne

    Article 17 March 2007 Pages: 1024 - 1032

    

19. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance

    • K. C. Lewandowski
    • N. Stojanovic
    • H. S. Randeva

    Short Communication 02 March 2007 Pages: 1033 - 1037

    

20. Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue

    • C. Moro
    • E. Klimcakova
    • D. Langin

    Article 23 February 2007 Pages: 1038 - 1047

    

21. Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor α/γ agonist on glucose uptake

    • X. Hu
    • Y. Feng
    • Y. Leng

    Article 01 March 2007 Pages: 1048 - 1057

    

22. Focal adhesion kinase regulates insulin resistance in skeletal muscle

    • B. Bisht
    • H. L. Goel
    • C. S. Dey

    Article 28 February 2007 Pages: 1058 - 1069

    

23. Characterisation of insulin-resistant phenotype of cultured rat primary adipose cells

    • C. C. Xiang
    • Y. J. Wu
    • X. Chen

    Article 23 March 2007 Pages: 1070 - 1079

    

24. Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator–activator receptor γ gene expression in macrophages

    • J. Graessler
    • J. Pietzsch
    • S. Kopprasch

    Article 23 March 2007 Pages: 1080 - 1088

    

25. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina

    • J. M. Hughes
    • E. J. Kuiper
    • R. O. Schlingemann

    Article Open access 28 February 2007 Pages: 1089 - 1098

    

26. In utero undernutrition reduces diabetes incidence in non-obese diabetic mice

    • A. Oge
    • E. Isganaitis
    • M. E. Patti

    Article 17 March 2007 Pages: 1099 - 1108

    

27. Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

    • D. Raccah

    Letter 10 March 2007 Pages: 1109 - 1110

28. Response to comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulphonylureas and metformin. Diabetologia 49:930–936

    • J. M. M. Evans
    • A. D. Morris

    Letter 10 March 2007 Pages: 1111 - 1111